DCF — KEARNEY REGIONAL MEDICAL CENTER
Enterprise Value: $-225.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-225.0M
Enterprise Value
$-71.5M
PV of Cash Flows
$-153.5M
PV of Terminal Value
$-247.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $150.3M | $-13.8M | -9.0% | $-20.2M | $-18.4M |
| Year 2 | $154.8M | $-12.7M | -8.0% | $-19.3M | $-15.9M |
| Year 3 | $159.4M | $-11.5M | -7.0% | $-18.2M | $-13.7M |
| Year 4 | $164.2M | $-11.0M | -7.0% | $-18.0M | $-12.3M |
| Year 5 | $169.1M | $-10.9M | -6.0% | $-18.1M | $-11.2M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-225.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$145.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09709752543715723
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5